Skip to main content
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

SIMPLY SOLVENTLESS ANNOUNCES OVER SUBSCRIPTION OF PREVIOUSLY ANNOUNCED CONVERTIBLE DEBENTURE FINANCING TO $6.0 MILLION & EXPECTED DELTA 9 BIO-TECH CLOSING DATE OF FEBRUARY 7, 2025

Newswire.ca - Mon Feb 3, 2025

/NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES./

CALGARY, AB, Feb. 3, 2025 /CNW/ - Simply Solventless Concentrates Ltd. (TSXV: HASH) ("SSC") is pleased to announce that due to very strong demand it intends to over subscribe the previously announced non-brokered secured convertible debenture unit ("Debenture Unit") financing from $5.0 million to $6.0 million (the "Offering") (see Debenture Unit financing announcement). $375,000 of the Offering is being subscribed by insiders.  SSC is pleased to also announce that it has received approval from the Court of King's Bench of Alberta pursuant to Delta 9 Cannabis Inc.'s proceedings under the Companies' Creditors Arrangement Act, to complete the acquisition of Delta 9 Bio-Tech ("Bio-Tech") as previously announced on December 30, 2024 (see Bio-Tech acquisition announcement).  SSC anticipates closing the strategic acquisition of Bio-Tech on or about February 7, 2025.

Read more at newswire.ca

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.